New UK HIV data spur calls for better access to testing
This article was originally published in Clinica
Executive Summary
The UK's Health Protection Agency (HPA) is calling for better access to HIV diagnostic testing services, in light of data published today showing that the incidence of infection is at its highest among injecting drug users (IDUs) for over a decade. The HPA's IDU expert, Dr Fortune Ncube, said that it was imperative too that there is sufficient access to needles and syringes, as well as improving advice on safe disposal of used devices.
You may also be interested in...
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.